Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice
Authors:
- 1 September 2014
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 21 (10) , 1208-1215
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2012R1A2A2A01012946)
- Ministry of Education, Science and Technology (2012H1B8A2026122)
This publication has 27 references indexed in Scilit:
- The pros and cons of plant estrogens for menopauseThe Journal of Steroid Biochemistry and Molecular Biology, 2014
- Alternative therapies for the prevention and treatment of osteoporosisNutrition Reviews, 2012
- Bisphosphonate therapy for osteoporosis: combining optimal fracture risk reduction with patient preferenceCurrent Medical Research and Opinion, 2011
- Olive polyphenol hydroxytyrosol prevents bone lossEuropean Journal of Pharmacology, 2011
- Physiology of the aging bone and mechanisms of action of bisphosphonatesBiogerontology, 2011
- Fracture risk associated with continuation versus discontinuation of bisphosphonates after 5 years of therapy in patients with primary osteoporosis: a systematic review and meta-analysisTherapeutics and Clinical Risk Management, 2011
- TGF-β Inducible Early Gene 1 Regulates Osteoclast Differentiation and Survival by Mediating the NFATc1, AKT, and MEK/ERK Signaling PathwaysPLOS ONE, 2011
- Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: An overviewJournal of Natural Science, Biology and Medicine, 2011
- Cellular mechanisms of bone remodelingReviews in Endocrine and Metabolic Disorders, 2010
- Osteoclastic differentiation and function regulated by old and new pathwaysReviews in Endocrine and Metabolic Disorders, 2006